Cargando…

Supplementary Therapeutic Possibilities to Alleviate Myocardial Damage Due to Microvascular Dysfunction in Coronavirus Disease 2019 (COVID-19)

Myocardial damage with a consequent rise in cardio-specific troponin level is a frequent phenomenon in severe cases of coronavirus disease 2019 (COVID-19). Its causes are capillary endothelial cell dysfunction, associated carditis, low oxygenization, and increased sympathetic tone, which all worsen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medvegy, Mihály, Simonyi, Gábor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018688/ https://www.ncbi.nlm.nih.gov/pubmed/33811310 http://dx.doi.org/10.1007/s40119-021-00216-8

Ejemplares similares

Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
por: Montone, Rocco A, et al.
Publicado: (2020)

Clinical Implications of Coronary Microvascular Dysfunction in Patients with CKD
por: Elbaum, Lindsay, et al.
Publicado: (2022)

Microvascular thrombi in recurrent myocardial injury after coronavirus disease 2019 infection
por: Aikawa, Tadao, et al.
Publicado: (2021)

Seeking Normalcy as the Curve Flattens: Ethical Considerations for Pediatricians Managing Collateral Damage of Coronavirus Disease-2019
por: Feltman, Dalia M., et al.
Publicado: (2020)

Mineralocorticoid Receptors: An Appealing Target to Treat Coronary Microvascular Dysfunction in Diabetes
por: Bender, Shawn B., et al.
Publicado: (2015)

Microvascular dysfunction in silent myocardial ischemia
por: Han, Chih-Lu, et al.
Publicado: (2017)

Commentary: Coronavirus disease 2019 in cardiac surgery: We are still learning and have yet to see all possible complications
por: Ramzy, Danny
Publicado: (2020)

Linking Coronary Microvascular and Cardiac Diastolic Dysfunction in Diabetes: Are Women More Vulnerable?
por: Bender, Shawn B.
Publicado: (2019)

Proposal for Coronavirus Disease 2019 Management
por: Downs, John B., et al.
Publicado: (2020)

Hypothetical Protective Effects of Crocin Carotenoid against Coronavirus-Induced Organ Damage: The Possible Role of the NF-κB Signaling Pathway
por: Gholami, Mina, et al.
Publicado: (2021)

Coronavirus 2019, Microthromboses, and Platelet Activating Factor
por: Theoharides, Theoharis C., et al.
Publicado: (2020)

Return of the Coronavirus: 2019-nCoV
por: Gralinski, Lisa E., et al.
Publicado: (2020)

Clinical Distancing and Mitigation of Coronavirus Disease 2019
por: Scott, Benjamin K., et al.
Publicado: (2020)

Thromboprophylaxis for medical inpatients with coronavirus disease 2019
por: Dalager-Pedersen, M., et al.
Publicado: (2020)

Commentary: The molecular pandemonium of coronavirus disease 2019
por: Balsam, Leora B., et al.
Publicado: (2021)

Is It Time for Coronavirus Disease-2019 Vaccine Mandates?
por: Bernstein, Henry H., et al.
Publicado: (2022)

Which are the best coronavirus disease 2019 vaccines?
por: Omrani, Ali S., et al.
Publicado: (2021)

Cancer patients and coronavirus disease 2019: evidence in context
por: Barba, Maddalena, et al.
Publicado: (2020)

Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?
por: Beer, Karlyn D., et al.
Publicado: (2020)

Shelter Hospital: Glimmers of Hope in Treating Coronavirus 2019
por: Zhou, Feng, et al.
Publicado: (2020)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

Preparedness for further boosting coronavirus disease 2019 vaccines
por: Lim, So Yun, et al.
Publicado: (2022)

Angina due to microvascular dysfunction with severe heart failure
por: Marzilli, Mario
Publicado: (2019)

Angina due to microvascular dysfunction and atrioventricular conduction defects
por: Lopatin, Yury
Publicado: (2019)

Implications of current and future approaches to coronavirus disease 2019 testing
por: Smith, Rasheid, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Vaccination of Children and Adolescents: Prospects and Challenges
por: Zimet, Gregory D., et al.
Publicado: (2021)

Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era
por: Dekker, Evelien, et al.
Publicado: (2020)

Commentary: Training in the time of coronavirus disease 2019 (COVID-19)
por: Tibayan, Frederick A.
Publicado: (2021)

2019 novel coronavirus outbreak: a quiz or final exam?
por: Xu, Jiuyang, et al.
Publicado: (2020)

The role of a Coronavirus disease 2019 pharmacist: an Australian perspective
por: Nguy, Jenny, et al.
Publicado: (2020)

Therapeutic potential of inhalable medications to combat coronavirus disease-2019
por: Parvathaneni, Vineela, et al.
Publicado: (2020)

Modeling the Epidemic Trend of the 2019 Novel Coronavirus Outbreak in China
por: Shen, Mingwang, et al.
Publicado: (2020)

Commentary: Obesity in the time of coronavirus disease 2019 (COVID-19)
por: Shah, Ashish S.
Publicado: (2021)

Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
por: Lau, Harry Cheuk-Hay, et al.
Publicado: (2022)

2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Liu, Peng, et al.
Publicado: (2020)

Arrhythmias in the Age of Coronavirus Disease 2019
por: Niazi, Imran, et al.
Publicado: (2021)

Health behaviours during the coronavirus disease 2019 pandemic: implications for obesity
por: Parekh, Niyati, et al.
Publicado: (2020)

Clinical Pharmacists: An Invaluable Part of the Coronavirus Disease 2019 Frontline Response
por: Ferguson, Nadia C., et al.
Publicado: (2020)

Treating Gastrointestinal Cancer During the Coronavirus Disease 2019 Pandemic in Europe
por: Collienne, Maike, et al.
Publicado: (2020)

N-acetylcysteine as a potential treatment for novel coronavirus disease 2019
por: Jorge-Aarón, Rangel-Méndez, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_po502fo1sit5a4uo34b1t39iva